We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Routine HIV Testing Will Help Destigmatize Disease

By LabMedica International staff writers
Posted on 07 Oct 2009
A third of human immunodeficiency virus (HIV)-related deaths could be avoided if testing for the disease was more widespread and more socially acceptable. More...
The introduction of universal testing is intended to destigmatize the process.

Guidelines for HIV testing called for tests to be offered to everyone accessing sexual health services, antenatal and abortion services, as well as drug dependency programs, and healthcare services for those diagnosed with tuberculosis. They should be routinely offered to anyone presenting with other clinical indicators for HIV infection, or with an identified risk factor for HIV whenever they access healthcare services.

Any doctor, nurse, midwife, or trained healthcare worker will be able to carry out HIV tests and help reduce late diagnoses of the virus. Treatment for people who discover they are HIV positive a long time after they have contracted the disease can be more difficult and while infected, they may have passed on the disease unknowingly.

The concise guidelines, which advocated normalization of HIV testing, were published on September 30, 2009 in Clinical Medicine the journal of the Royal College of Physicians (London, UK). The guidance was prepared on behalf of the HIV Testing Guidelines Writing Committee, and is a summary of the recommendations from the UK national guidelines for HIV testing 2008 produced by the British HIV Association.

The publication of these guidelines will be supported by a new HIV testing resource pack for clinicians produced by the Medical Foundation for AIDS and Sexual Health (MedFASH; London; UK), which will be launched at the British HIV Association Autumn conference 2009, on the 8th October, in London (UK).

Related Links:

Royal College of Physicians
British HIV Association
Medical Foundation for AIDS and Sexual Health



Gold Member
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
POC Helicobacter Pylori Test Kit
Hepy Urease Test
New
Automated Chemiluminescence Immunoassay Analyzer
MS-i3080
New
Rapid Test Reader
DIA5000
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Hematology

view channel
Image: The microfluidic device for passive separation of platelet-rich plasma from whole blood (Photo courtesy of University of the Basque Country)

Portable and Disposable Device Obtains Platelet-Rich Plasma Without Complex Equipment

Platelet-rich plasma (PRP) plays a crucial role in regenerative medicine due to its ability to accelerate healing and repair tissue. However, obtaining PRP traditionally requires expensive centrifugation... Read more

Immunology

view channel
Image: PD-1 protein blockade is the standard treatment for advanced melanoma among the different types of immunotherapy (Photo courtesy of 123RF)

Precision Tool Predicts Immunotherapy Treatment Failure in Melanoma Patients

Melanoma, though accounting for only about 4% of skin tumors, is the deadliest form of skin cancer due to its high potential to metastasize. While immunotherapy, especially PD-1 protein blockade, has revolutionized... Read more

Pathology

view channel
Image: Genai-based pathological assessment workflow for lung adenocarcinoma (Shen J. et al., Int J Surg 111(7): 4252–4262; 2025)

Generative AI Demonstrates Expert-Level Pathological Assessment of Lung Cancer

Lung adenocarcinoma is one of the most difficult cancers to diagnose accurately, requiring pathologists to spend extensive time examining tissue samples under microscopes to determine tumor grades and... Read more

Industry

view channel
Image: Alzheimer’s Association has released its first clinical practice guideline for blood-based biomarker tests (Photo courtesy of Alzheimer’s Association)

New Clinical Guidelines Recommend Use of Blood Tests Instead of Brain Scans for Alzheimer’s Diagnosis

Alzheimer’s disease is a progressive neurodegenerative condition that remains challenging to diagnose early and accurately, particularly in individuals with cognitive impairment. Despite the availability... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.